Revelation Biosciences Warrant
REVBW
12 hedge funds and large institutions have $123K invested in Revelation Biosciences Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
34% more capital inflows, than outflows
Capital inflows: $32.3K | Capital outflows: $24.1K
29% less funds holding
Funds holding: 17 → 12 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Linden Advisors
New York
|
+$30.7K |
| 2 |
Jane Street
New York
|
+$1.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$9K |
| 2 |
Capstone Investment Advisors
New York
|
-$7K |
| 3 |
Walleye Trading
New York
|
-$5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.11K |
| 5 |
Flow Traders U.S.
New York
|
-$1K |
REVBW Hedge Fund Activity: Q3 2022 in Review
12 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2022, worth a combined $123K — down 41% from $208K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of REVBW and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Linden Advisors, adding an estimated $30.7K. The largest seller was Walleye Capital, exiting entirely with an estimated $9K sold.
- 12 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2022, down from 17 in Q2 2022.
- Funds reported $123K of Revelation Biosciences Warrant stock for Q3 2022, down 41% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences Warrant positions in Q3 2022 and 5 closed out, a net change of -5 holders.
- The largest Revelation Biosciences Warrant buyer in Q3 2022 was Linden Advisors, an estimated $30.7K added.
- The largest Revelation Biosciences Warrant seller in Q3 2022 was Walleye Capital, an estimated $9K sold.
Based on aggregated 13F filings for Q3 2022.